XML 22 R8.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Statement of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 30, 2017
Dec. 31, 2016
Jan. 02, 2016
Operating Activities      
Net Income Attributable to Kadant $ 31,092 $ 32,077 $ 34,389
Net income attributable to noncontrolling interest 491 392 294
Income from discontinued operation 0 (3) (74)
Income from continuing operations 31,583 32,466 34,609
Adjustments to reconcile income from continuing operations to net cash provided by operating activities:      
Depreciation and amortization 19,375 14,326 10,821
Stock-based compensation expense 5,803 5,069 5,741
Excess tax benefit from stock-based compensation awards 0 0 (881)
Provision for losses on accounts receivable 436 453 379
Loss (gain) on sale of property, plant, and equipment 42 (350) 4
Deferred income tax benefit 578 (613) (1,706)
Other items, net 1,420 1,362 (287)
Contributions to U.S. pension plan (1,080) (1,080) (1,080)
Changes in current assets and liabilities, net of effects of acquisitions:      
Accounts receivable (10,907) 1,003 (10,640)
Unbilled contract costs and fees 1,310 3,407 (1,534)
Inventories 1,163 3,553 (6,486)
Other current assets (130) 753 1,495
Accounts payable (522) (5,238) (1,752)
Other current liabilities 16,093 (4,111) 11,727
Net cash provided by continuing operations 65,164 51,000 40,410
Net cash provided by (used in) discontinued operation 0 3 (38)
Net cash provided by operating activities 65,164 51,003 40,372
Investing Activities      
Acquisitions, net of cash acquired (Note 2) (204,731) (56,617) 0
Purchases of property, plant, and equipment (17,281) (5,804) (5,479)
Proceeds from sale of property, plant, and equipment 130 428 30
Net cash used in continuing operations for investing activities (221,882) (61,993) (5,449)
Financing Activities      
Proceeds from issuance of debt (Note 6) 232,019 51,046 24,000
Repayment of debt (67,696) (18,429) (18,611)
Dividends paid (9,011) (8,038) (7,179)
Tax withholding payments related to stock-based compensation (2,206) (2,572) (2,499)
Payment of debt issuance costs (Note 6) (1,257) (27) 0
Change in restricted cash 880 (789) (1,066)
Dividend paid to noncontrolling interest (882) 0 0
Purchases of Company common stock 0 0 (9,906)
Proceeds from issuance of Company common stock 0 2,350 754
Payment of contingent consideration (Note 2) 0 (1,091) 0
Excess tax benefits from stock-based compensation awards 0 0 881
Other financing activities (491) 216 0
Net cash provided by (used in) continuing operations for financing activities 151,356 22,666 (13,626)
Exchange Rate Effect on Cash and Cash Equivalents from Continuing Operations 9,300 (5,714) (1,145)
Decrease in Cash from Discontinued Operation 0 (5) 0
Increase in Cash and Cash Equivalents from Continuing Operations 3,938 5,957 20,152
Cash and Cash Equivalents at Beginning of Year 71,487 65,530 45,378
Cash and Cash Equivalents at End of Year $ 75,425 $ 71,487 $ 65,530